(FTK) Flotek Industries - Overview
Stock: Green Chemicals, Data Analytics, Sensor Solutions, Specialty Chemistries
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 102% |
| Relative Tail Risk | -21.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.17 |
| Alpha | 67.96 |
| Character TTM | |
|---|---|
| Beta | 1.776 |
| Beta Downside | 1.729 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.81% |
| CAGR/Max DD | 0.57 |
Description: FTK Flotek Industries December 27, 2025
Flotek Industries, Inc. (NYSE:FTK) is a Houston-based provider of green-chemistry specialty products and real-time data analytics for the energy sector, operating in the United States, the United Arab Emirates, and other international markets.
The company’s Chemistry Technologies (CT) segment manufactures and packages environmentally-focused specialty chemicals that improve the profitability of hydrocarbon producers and serve a range of customers, including integrated oil & gas firms, independent producers, national oil companies, and renewable-energy players such as geothermal and solar operators. The Data Analytics (DA) segment sells measurement and monitoring solutions that deliver real-time emissions data, enabling customers to optimize operations and lower carbon intensity.
In FY 2023 Flotek reported $215 million in revenue, with the CT segment contributing roughly 68 % and the DA segment 32 %. EBITDA margin hovered around 12 %, reflecting the capital-intensive nature of specialty chemicals but also the higher margin potential of data-driven services. Key economic drivers include oil-price volatility, which can boost demand for efficiency-enhancing chemicals, and tightening ESG regulations that accelerate adoption of emissions-monitoring technology.
For a deeper quantitative view of FTK’s valuation and risk profile, consider exploring the company’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 31.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -4.26 > 1.0 |
| NWC/Revenue: 19.75% < 20% (prev 23.29%; Δ -3.54% < -1%) |
| CFO/TA -0.01 > 3% & CFO -2.09m > Net Income 31.9m |
| Net Debt (9.57m) to EBITDA (25.3m): 0.38 < 3 |
| Current Ratio: 1.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.1m) vs 12m ago 23.43% < -2% |
| Gross Margin: 25.55% > 18% (prev 0.20%; Δ 2534 % > 0.5%) |
| Asset Turnover: 118.1% > 50% (prev 111.1%; Δ 7.04% > 0%) |
| Interest Coverage Ratio: 8.02 > 6 (EBITDA TTM 25.3m / Interest Expense TTM 2.82m) |
Altman Z'' -5.24
| A: 0.20 (Total Current Assets 100.0m - Total Current Liabilities 56.5m) / Total Assets 212.7m |
| B: -1.36 (Retained Earnings -288.8m / Total Assets 212.7m) |
| C: 0.12 (EBIT TTM 22.6m / Avg Total Assets 186.7m) |
| D: -2.83 (Book Value of Equity -288.7m / Total Liabilities 102.2m) |
| Altman-Z'' Score: -5.24 = D |
Beneish M -2.88
| DSRI: 0.98 (Receivables 79.8m/65.8m, Revenue 220.5m/178.5m) |
| GMI: 0.80 (GM 25.55% / 20.48%) |
| AQI: 1.02 (AQ_t 0.42 / AQ_t-1 0.41) |
| SGI: 1.24 (Revenue 220.5m / 178.5m) |
| TATA: 0.16 (NI 31.9m - CFO -2.09m) / TA 212.7m) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of FTK shares?
Over the past week, the price has changed by -0.23%, over one month by -10.49%, over three months by +14.16% and over the past year by +99.88%.
Is FTK a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FTK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19 | 9.6% |
| Analysts Target Price | 19 | 9.6% |
| ValueRay Target Price | 20.5 | 18.5% |
FTK Fundamental Data Overview February 03, 2026
P/E Forward = 23.8095
P/S = 2.3678
P/B = 5.046
P/EG = 4.78
Revenue TTM = 220.5m USD
EBIT TTM = 22.6m USD
EBITDA TTM = 25.3m USD
Long Term Debt = 39.6m USD (from longTermDebt, last quarter)
Short Term Debt = 8.03m USD (from shortTermDebt, last quarter)
Debt = 14.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.57m USD (from netDebt column, last quarter)
Enterprise Value = 531.7m USD (522.1m + Debt 14.2m - CCE 4.60m)
Interest Coverage Ratio = 8.02 (Ebit TTM 22.6m / Interest Expense TTM 2.82m)
EV/FCF = -101.6x (Enterprise Value 531.7m / FCF TTM -5.23m)
FCF Yield = -0.98% (FCF TTM -5.23m / Enterprise Value 531.7m)
FCF Margin = -2.37% (FCF TTM -5.23m / Revenue TTM 220.5m)
Net Margin = 14.48% (Net Income TTM 31.9m / Revenue TTM 220.5m)
Gross Margin = 25.55% ((Revenue TTM 220.5m - Cost of Revenue TTM 164.2m) / Revenue TTM)
Gross Margin QoQ = 30.70% (prev 24.69%)
Tobins Q-Ratio = 2.50 (Enterprise Value 531.7m / Total Assets 212.7m)
Interest Expense / Debt = 9.53% (Interest Expense 1.35m / Debt 14.2m)
Taxrate = 5.82% (649.0k / 11.1m)
NOPAT = 21.3m (EBIT 22.6m * (1 - 5.82%))
Current Ratio = 1.77 (Total Current Assets 100.0m / Total Current Liabilities 56.5m)
Debt / Equity = 0.13 (Debt 14.2m / totalStockholderEquity, last quarter 110.5m)
Debt / EBITDA = 0.38 (Net Debt 9.57m / EBITDA 25.3m)
Debt / FCF = -1.83 (negative FCF - burning cash) (Net Debt 9.57m / FCF TTM -5.23m)
Total Stockholder Equity = 104.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 17.11% (Net Income 31.9m / Total Assets 212.7m)
RoE = 30.71% (Net Income TTM 31.9m / Total Stockholder Equity 104.0m)
RoCE = 15.73% (EBIT 22.6m / Capital Employed (Equity 104.0m + L.T.Debt 39.6m))
RoIC = 16.62% (NOPAT 21.3m / Invested Capital 127.9m)
WACC = 12.37% (E(522.1m)/V(536.3m) * Re(12.46%) + D(14.2m)/V(536.3m) * Rd(9.53%) * (1-Tc(0.06)))
Discount Rate = 12.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 11.83%
Fair Price DCF = unknown (Cash Flow -5.23m)
EPS Correlation: 82.68 | EPS CAGR: 92.54% | SUE: 4.0 | # QB: 1
Revenue Correlation: 70.62 | Revenue CAGR: 50.31% | SUE: 0.45 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.15 | Chg30d=-0.040 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.88 | Chg30d=-0.085 | Revisions Net=-1 | Growth EPS=-3.9% | Growth Revenue=+12.0%